188 related articles for article (PubMed ID: 31358038)
1. Sarcoid- like Phenomenon - ustekinumab induced granulomatous reaction mimicking diffuse metastatic disease: a case report and review of the literature.
Gad MM; Bazarbashi N; Kaur M; Gupta A
J Med Case Rep; 2019 Jul; 13(1):257. PubMed ID: 31358038
[TBL] [Abstract][Full Text] [Related]
2. [Drug-induced interstitial lung disease (DILD) during treatment with ustekinumab].
Sorger C; Simon JC; Treudler R
Hautarzt; 2020 Apr; 71(4):309-312. PubMed ID: 31792580
[TBL] [Abstract][Full Text] [Related]
3. Rapidly recurring massive pleural effusion as the initial presentation of sarcoidosis: A case report.
Albakri M; Ahmad M; Mohamed MFH
Medicine (Baltimore); 2021 Feb; 100(6):e24027. PubMed ID: 33578518
[TBL] [Abstract][Full Text] [Related]
4. [Acute sarcoid myopathy and neuropathy aggravated by ustekinumab administration in an elderly woman with psoriasis and systemic sarcoidosis].
Sano H; Maeda T; Sato R; Shimizu F; Koga M; Kanda T
Rinsho Shinkeigaku; 2022 Jun; 62(6):475-480. PubMed ID: 35644583
[TBL] [Abstract][Full Text] [Related]
5. Rare coexistence of sarcoidosis and lung adenocarcinoma.
Kachalia AG; Ochieng P; Kachalia K; Rahman H
Respir Med Case Rep; 2014; 12():4-6. PubMed ID: 26029525
[TBL] [Abstract][Full Text] [Related]
6. [Ustekinumab-induced eosinophilic pneumonia during the course of ustekinumab therapy for plaque psoriasis].
Amy de la Bretèque M; Appere-De Vecchi C; Zeboulon C; Zaien I; Sigal ML; Mahé E
Ann Dermatol Venereol; 2015 Mar; 142(3):193-6. PubMed ID: 25624139
[TBL] [Abstract][Full Text] [Related]
7. Disseminated sporotrichosis mimicking sarcoidosis.
Yang DJ; Krishnan RS; Guillen DR; Schmiege LM; Leis PF; Hsu S
Int J Dermatol; 2006 Apr; 45(4):450-3. PubMed ID: 16650176
[TBL] [Abstract][Full Text] [Related]
8. Ustekinumab-induced Sarcoidosis in a Patient with Psoriatic Arthritis.
Kobak S; Semiz H
Curr Drug Saf; 2020; 15(2):163-166. PubMed ID: 32178618
[TBL] [Abstract][Full Text] [Related]
9. A Case of Severe Transaminase Elevation Following a Single Ustekinumab Dose with Remission After Drug Withdrawal.
Lovero R; Losurdo G; Mastromauro M; Castellaneta NM; Mongelli A; Gentile A; Di Leo A; Principi M
Curr Drug Saf; 2018; 13(3):221-223. PubMed ID: 30027852
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.
Gordon KB; Strober B; Lebwohl M; Augustin M; Blauvelt A; Poulin Y; Papp KA; Sofen H; Puig L; Foley P; Ohtsuki M; Flack M; Geng Z; Gu Y; Valdes JM; Thompson EHZ; Bachelez H
Lancet; 2018 Aug; 392(10148):650-661. PubMed ID: 30097359
[TBL] [Abstract][Full Text] [Related]
11. Inverse psoriasis treated with ustekinumab.
Campos MA; Varela P; Baptista A; Moreira AI
BMJ Case Rep; 2016 May; 2016():. PubMed ID: 27222277
[TBL] [Abstract][Full Text] [Related]
12. Ocular toxoplasmosis in a patient treated with ustekinumab for psoriasis.
Javadzadeh S; Gkini MA; Panos GD; Adewoyin T; Bewley A
Clin Exp Dermatol; 2020 Aug; 45(6):802-804. PubMed ID: 32212270
[No Abstract] [Full Text] [Related]
13. Long-term therapy with ustekinumab for psoriasis in a patient with a history of malignant melanoma.
Gkalpakiotis S; Arenberger P; Fridman M; Arenbergerova M
Dermatol Ther; 2017 Nov; 30(6):. PubMed ID: 28730674
[No Abstract] [Full Text] [Related]
14. Development of hidradenitis suppurativa in a patient treated with ustekinumab for her psoriasis: A potential paradoxical reaction?
Gkini MA; Bewley AP
Dermatol Ther; 2018 Nov; 31(6):e12742. PubMed ID: 30221819
[No Abstract] [Full Text] [Related]
15. Efficacy and safety of guselkumab in patients with psoriasis who have an inadequate response to ustekinumab: results of the randomized, double-blind, phase III NAVIGATE trial.
Langley RG; Tsai TF; Flavin S; Song M; Randazzo B; Wasfi Y; Jiang J; Li S; Puig L
Br J Dermatol; 2018 Jan; 178(1):114-123. PubMed ID: 28635018
[TBL] [Abstract][Full Text] [Related]
16. Varicella zoster virus meningitis under ustekinumab because of plaque psoriasis.
Stöllberger C; Finsterer J
J Dermatol; 2017 Jun; 44(6):703-705. PubMed ID: 28150333
[TBL] [Abstract][Full Text] [Related]
17. Paradoxical ulcerative colitis during adalimumab treatment of psoriasis resolved by switch to ustekinumab.
Kolios AGA; Biedermann L; Weber A; Navarini AA; Meier J; Cozzio A; French LE
Br J Dermatol; 2018 Feb; 178(2):551-555. PubMed ID: 28477389
[TBL] [Abstract][Full Text] [Related]
18. Long-term efficacy and safety of ustekinumab, with and without dosing adjustment, in patients with moderate-to-severe psoriasis: results from the PHOENIX 2 study through 5 years of follow-up.
Langley RG; Lebwohl M; Krueger GG; Szapary PO; Wasfi Y; Chan D; Hsu MC; You Y; Poulin Y; Korman N; Prinz JC; Reich K;
Br J Dermatol; 2015; 172(5):1371-83. PubMed ID: 25307931
[TBL] [Abstract][Full Text] [Related]
19. Sarcoidosis in a 65-year-old woman presenting with a lung mass and pericardial effusion: a case report.
Margaritopoulos GA; Proklou A; Lagoudaki E; Voloudaki A; Siafakas NM; Antoniou KM
J Med Case Rep; 2012 Aug; 6():259. PubMed ID: 22937889
[TBL] [Abstract][Full Text] [Related]
20. Hepato-bronchial fistula secondary to perforated sigmoid diverticulitis: a case report.
Yin JS; Govind S; Wiseman D; Inculet R; Kao R
J Med Case Rep; 2017 Apr; 11(1):106. PubMed ID: 28403899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
